> SARS-CoV-2 isn't very novel. The long-term clinical effects appear to be fairly similar to SARS-CoV and MERS-CoV Sure, novel is a sliding scale. But it has b

> SARS-CoV-2 isn't very novel. The long-term clinical effects appear to be fairly similar to SARS-CoV and MERS-CoV Sure, novel is a sliding scale. But it has been novel enough for our immune systems, and that is sufficient reason to be cautious. Also its epidemiologic profile was sufficiently different that our knowledge with sars or mers didn’t help us being in a pandemic right now, which can’t be entirely explained with bad policy decisions.